Normal ultrastructure, but altered stratum corneum lipid and protein composition in a mouse model for epidermolytic hyperkeratosis

Journal of Investigative Dermatology

Volumn 113, Issue 3, 1999, Pages 329-334

  Reichelt, Julia ^c   Doering, Thomas ^a   Schnetz, Esther ^b   Fartasch, Manigé ^b   Sandhoff, Konrad ^a   Magin, Thomas M ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Abt Molekulargenetik ^*

Author keywords

Ceramide; Involucrin; Keratin 10; Lamellar body

Indexed keywords

CERAMIDE; GLUCOSYLCERAMIDE; KERATIN; LORICRIN; SPHINGOMYELIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HETEROZYGOSITY; HOMOZYGOSITY; HYPERKERATOSIS; ICHTHYOSIS; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STRATUM CORNEUM; ULTRASTRUCTURE;

EID: 0032835593     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00702.x     Document Type: Article

References (50)

1. Bickenbach JR, Longley MA, Bundman DS, Dominey AM, Bowden PE, Rothnagel JA, Roop DR: A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis. Differentiation 61:129-139, 1996
2. Candi E, Tarcsa E, Digiovanna JJ, Compton JG, Elias PM, Marekov LN, Steinert PM: A highly conserved lysine residue in the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornifided cell envelope through isopeptide crosslinking by transglutaminases. Proc Natl Acad Sci USA 95:2067-2072, 1998
3. Candi E, Tarcsa E, Idler WW, Kartasova T, Marekov LN, Steinert PM: Transglutaminase cross-linking properties of the small proline-rich 1 family of cornified cell envelope proteins, Integration with lorictin. J Biol Chem 274:7226-7237, 1999
4. Cheng J, Syder AJ, Yu QC, Letai A, Paller AS, Fuchs E: The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 70:811-819, 1992
5. Chipev CC, Yang JM, DiGiovanna JJ, Steinert PM, Marekov L, Compton JG, Bale SJ: Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am J Hum Genet 54:179-190, 1994
6. Chomezynski P, Sacchi N: Single-step method of RNA isolation. Anal Biochem 162:156-159, 1987
7. Corden LD, McLean WH: Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol 5:297-307, 1996
8. Doering T, Holleran WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K: Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem 274:11038-11045, 1999
9. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24:1-26, 1991
10. Elias PM, Brown BE, Fritsch P, Goerke J, Gray GM, White J: Localization and composition of lipids in neonatal mouse stratum granulosum and stratum corneum. J Invest Dermatol 73:339-348, 1979
11. Fartasch M: Epidermal barrier in disorders of the skin. Microscopy Res Technique 38:361-372, 1997
12. Fartasch M, Ponec M: Improved barrier structure formation in air-exposed human keratinocyte culture systems. J Invest Dermatol 102:366-374, 1994
13. Fartasch M, Bassukas ID, Diepgen TL: Structural relationship between epidermal lipid lamellae, lamellar bodies and desmosomes in human epidermis: an ultrastructural study. Br J Dermatol 128:1-9, 1993
14. Freinkel RK, Traczyk TN: Lipid composition and acid hydrolase content of lamellar granules of fetal rat epidermis. J Invest Dermatol 85:295-298, 1985
15. Frost P, Weinstein GD, Bothwell JW, Wildnauer R: Ichthyosiform dermatoses. Arch Dermatol 98:230-233, 1968
16. Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 63:345-382, 1994
17. Fuchs E, Esteves RA, Coulombe PA: Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci USA 89:6906-6910, 1992
18. Ghadially R, Williams ML, Hou SY, Elias PM: Membrane structural abnormalities in the stratum corneum of the autosomal recessive ichthyoses. J Invest Dermatol 99:755-763, 1992
19. Grayson S, Johnson Winegar AC, Wintroub BU, Isseroff RR, Epstein EH Jr, Elias PM: Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol 85:289-294, 1985
20. Harris IR, Farell AM, Grunfeld C, Holleran WM, Elias PM, Feingold KR: Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol 106:783-787, 1997
21. Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 32:1151-1158, 1991
22. Huber M, Rettler I, Bernasconi K, et al: Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Sci 267:525-528, 1995
23. Ishida-Yamamoto A, Iizuka H, Manabe M, et al: Altered distribution of keratinization markers in epidermolytic hyperkeratosis. Arch Dermatol Res 287:705-711, 1995
24. Kanitakis J, Zambruno G, Viac J, Thivolet J: Involucrin expression in keratinization disorders of the skin-a preliminary study. Br J Dermatol 117:479-486, 1987
25. Lampe MA, Williams ML, Elias PM: Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 24:131-140, 1983
26. Landmann L: Epidermal permeability barrier: transformation of lamellar granule disks into intercellular sheets by a membrane-fusion process, a freeze-fracture study. J Invest Dermatol 87:202-209, 1986
27. Langbein L, Held HW, Moll I, Franke WW: Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression. Differentiation 55:57-71, 1993
28. Madison KC, Swartzendruber DC, Wertz PW, Downing DT: Sphingolipid metabolism in organotypic mouse keratinocyte cultures. J Invest Dermatol 95:657-664, 1990
29. Macstrini E, Monaco AP, McGrath JA, et al: A molecular defect in loricrin, the major component of the cornified envelope, underlies Vohwinkel's syndrome. Nat Genet 13:70-77, 1996
30. Magin TM: Lessons from keratin transgenic and knockout mice. In: Subcelluar Biochemistry, Vol. 31, Intermediate Filaments. New York: Plenum Press, 1998, pp 141-172
31. Magin TM, Schröder R., Leitgeb S, Wanninger F, Zatloukal K, Grund C, Melton DW: Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J Cell Biol 140:1441-1451, 1998
32. Marekov LN, Steinert PM: Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 273:17763-17770, 1998
33. Ming ME, Daryanani HA, Roberts LP, Baden HP, Kvedar JC: Binding of keratin intermediate filaments (K10) to the cornified envelope in mouse epidermis: implications for barrier function. J Invest Dermatol 103:780-784. 1994
34. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24, 1982
35. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R: Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1182: 147-151, 1993
36. Nemes Z, Marekov LN, Steinert PM: Involucrin cross-linking by transglutaminase 1. Binding to membranes directs residue specificity. J Biol Chem 274: 11013-11021, 1999
37. Paige DG, Morse Fisher N, Harper JI: Quantification of stratum corneum ceramides and lipid envelope ceramides in the hereditary ichthyoses. Br J Dermatol 131:23-27, 1994
38. Ponec M, Weerheim A, Mommaas AM, Nugteren DH: Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res 29:949-960, 1988
39. Porter RM, Leitgeb S, Melton DW, Swensson O, Eady RAJ, Magla TM: Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermus. J Cell Biol 132:925-936, 1996
40. Porter RM, Reichelt J, Lunny DP, Magin TM, Lane EB: The relationship between hyperproliferation and epidermal thickening in a mouse model for BCJE. J Invest Dermatol 110:951-957, 1998
41. Reichelt J, Bauer C, Porter R, Lane E, Magin M: Out of balance: consequences of a partial keratin 10 knockout. J Cell Sci 110:2175-2186, 1997
42. Rentrop M, Nischt R, Knapp B, Schweizer J, Winter H: An unusual type-II 70-kilodalton keratin protein of mouse epidermis exhibiting postnatal body-site specificity and sensitivity to hyperproliferation. Differentiation 34:189-200, 1987
43. Robson KJ, Stewart ME, Michelsen S, Lazo MD, Downing DT: 6-Hydroxy-4-sphingenin in human epidermal ceramides. J Lipid Res 35:2060-2068, 1994
44. Rothnagel JA, Dominey AM, Dempsey LD, et al: Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 257:1128-1130, 1992
45. Sambrook J, Fritsch EF, Maniatis T, Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989. pp 7.39-37.52
46. Steinert PM, Marekov LN: The proteins clafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 270:17702-17711, 1995
47. Steinert PM, Marekov LN: Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified cell envelope. J Biol Chem 272:2021-2030, 1997
48. Swartzendruber DC, Wertz PW, Madison KC, Downing DT: Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 88:709-713, 1987
49. Takahashi K, Coulombe PA: A transgenic mouse model with an inducible skin blistering disease phenotype. Proc Natl Acad Sci USA 93:14776-14781, 1996
50. Williams ML: Lipids in normal and pathological desquamation. Adv Lipid Res 24:211-262, 1991